Cruz Rivera, Samantha
Liu, Xiaoxuan http://orcid.org/0000-0002-1286-0038
Chan, An-Wen
Denniston, Alastair K. http://orcid.org/0000-0001-7849-0087
Calvert, Melanie J. http://orcid.org/0000-0002-1856-837X
,
,
Darzi, Ara
Holmes, Christopher
Yau, Christopher
Moher, David
Ashrafian, Hutan
Deeks, Jonathan J.
Ferrante di Ruffano, Lavinia
Faes, Livia
Keane, Pearse A.
Vollmer, Sebastian J.
,
Lee, Aaron Y.
Jonas, Adrian
Esteva, Andre
Beam, Andrew L.
Panico, Maria Beatrice
Lee, Cecilia S.
Haug, Charlotte
Kelly, Christophe J.
Yau, Christopher
Mulrow, Cynthia
Espinoza, Cyrus
Fletcher, John
Moher, David
Paltoo, Dina
Manna, Elaine
Price, Gary
Collins, Gary S.
Harvey, Hugh
Matcham, James
Monteiro, Joao
ElZarrad, M. Khair
Ferrante di Ruffano, Lavinia
Oakden-Rayner, Luke
McCradden, Melissa
Keane, Pearse A.
Savage, Richard
Golub, Robert
Sarkar, Rupa
Rowley, Samuel
Funding for this research was provided by:
Wellcome Trust
Alan Turing Institute
Article History
Received: 24 April 2020
Accepted: 23 July 2020
First Online: 9 September 2020
Competing interests
: M.J.C. has received personal fees from Astellas, Takeda, Merck, Daiichi Sankyo, Glaukos, GlaxoSmithKline and the Patient-Centered Outcomes Research Institute (PCORI) outside the submitted work. P.A.K. is a consultant for DeepMind Technologies, Roche, Novartis and Apellis, and has received speaker fees or travel support from Bayer, Allergan, Topcon and Heidelberg Engineering. C.J.K. is an employee of Google and owns Alphabet stock. A.E. is an employee of Salesforce CRM. R.S. is an employee of Pinpoint Science. J. Matcham was an employee of AstraZeneca at the time of this study. J. Monteiro is Chief Editor of the journal <i>Nature Medicine</i>; he has recused himself from any aspect of decision-making on this manuscript and played no part in the assignment of this manuscript to in-house editors or peer reviewers, and was also separated and blinded from the editorial process from submission inception to decision.